company

National Institute of Neurological Disorders and Stroke (NINDS)

as of 2026-07-01
at a glance
3 trials sponsored · 4 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

4 assets

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
EMD 128130
small molecule
drug
IV Levodopa
small molecule
drug
MRI
PROCEDURE
drug